Blue Clay Health, a pioneering healthcare technology company, today announced the appointment of Andrew Livingston as a Board Advisor.
We are thrilled to have Andrew join us as we continue to revolutionize care for complex medical patients.”
— Chris Riley
MIAMI, FL, UNITED STATES, February 27, 2025 /EINPresswire.com/ -- Blue Clay Health, a pioneering healthcare technology company, today announced the appointment of Andrew Livingston as a Board Advisor. With a proven track record in scaling digital health ventures, commercialization strategy, and user
experience innovation, Livingston will provide strategic guidance as Blue Clay Health advances its mission to revolutionize patient care through technology.
"We are thrilled to welcome Andrew
company's Founder and CEO. His expertise in telemedicine, commercialization, and digital transformation will be instrumental as we continue to enhance our platform and expand our impact. Andrew’s deep understanding of scaling digital health solutions and driving patient- centered innovation aligns perfectly with our mission."
Livingston brings extensive leadership experience in digital health, including co-founding and scaling Doxy.me, which has established itself as one of the world’s largest SaaS telemedicine platforms, serving over 1.2 million healthcare providers and facilitating more than 8 billion minutes of telemedicine. Additionally, he co-founded Visionology, a pioneer in the Eyecare-as-a-Service model. As Chief Innovation Officer at Harrow (NASDAQ: HROW), he led strategic
CEO initiatives that drove innovation and growth across Harrow and its subsidiaries, including ImprimisRx, one of the largest mail-order pharmacies in the U.S., transforming the patient
experience and enhancing digital engagement strategies. Currently, Livingston also advises DermaSensor, an AI-powered skin cancer detection company, focusing on market expansion and commercial strategy. He also serves on the University of Tennessee Advisory
Board for Digital Marketing, providing strategic insights into digital growth and innovation.
In his new role as Board Advisor, Livingston will:
• Provide strategic insights to support the company’s commercialization and growth
initiatives
• Leverage his expertise in digital transformation and user experience innovation to guide
Blue Clay Health’s expansion within the healthcare space
• Utilize his industry connections and knowledge of healthcare market dynamics to foster partnerships and business development opportunities
• Help shape the evolution of Ensemble Care Hub, ensuring it remains at the forefront of digital healthcare innovation
“I am honored to join Blue Clay Health as a Board Advisor," said Andrew Livingston. "The company’s commitment to leveraging technology to improve patient outcomes resonates deeply with my passion for scaling high-impact healthcare solutions. I look forward to helping Blue Clay Health achieve its next stage of growth and innovation."
Livingston’s appointment reinforces Blue Clay Health’s commitment to assembling top industry leaders to further its mission of delivering AI-powered, patient-centered digital healthcare solutions.
No comments:
Post a Comment